De Angelis Claudio Giovanni, Dall'Amico Eleonora, Staiano Maria Teresa, Gesualdo Marcantonio, Bruno Mauro, Gaia Silvia, Sacco Marco, Fimiano Federica, Mauriello Anna, Dibitetto Simone, Canalis Chiara, Stasio Rosa Claudia, Caneglias Alessandro, Mediati Federica, Rocca Rodolfo
Gastroenterology and Digestive Endoscopy Unit, AOU Città della Salute e della Scienza, University of Turin, 10126 Turin, Italy.
Gastroenterology Department, Mauriziano Hospital, 10128 Turin, Italy.
Diagnostics (Basel). 2023 Oct 20;13(20):3265. doi: 10.3390/diagnostics13203265.
Endoscopic ultrasound (EUS) and endoscopic retrograde cholangiopancreatography (ERCP) are both crucial for the endoscopic management of biliopancreatic diseases: the combination of their diagnostic and therapeutic potential is useful in many clinical scenarios, such as indeterminate biliary stenosis, biliary stones, chronic pancreatitis and biliary and pancreatic malignancies. This natural and evident convergence between EUS and ERCP, which by 2006 we were calling the "Endoscopic ultrasonography retrograde colangiopancreatography (EURCP) concept", has become a hot topic in the last years, together with the implementation of the therapeutic possibilities of EUS (from EUS-guided necrosectomy to gastro-entero anastomoses) and with the return of ERCP to its original diagnostic purpose thanks to ancillary techniques (extraductal ultrasound (EDUS), intraductal ultrasound (IDUS), cholangiopancreatoscopy with biopsies and probe-based confocal laser endomicroscopy (pCLE)). In this literary review, we retraced the recent history of EUS and ERCP, reported examples of the clinical applicability of the EURCP concept and explored the option of performing the two procedures in only one endoscopic session, with its positive implications for the patient, the endoscopist and the health care system. In the last few years, we also evaluated the possibility of combining EUS and ERCP into a single endoscopic instrument in a single step, but certain obstacles surrounding this approach remain.
内镜超声(EUS)和内镜逆行胰胆管造影(ERCP)对于胆胰疾病的内镜治疗均至关重要:它们诊断和治疗潜力的结合在许多临床场景中都很有用,例如不明原因的胆管狭窄、胆石症、慢性胰腺炎以及胆管和胰腺恶性肿瘤。EUS和ERCP之间这种自然而明显的融合,到2006年我们称之为“内镜超声逆行胰胆管造影(EURCP)概念”,在过去几年里已成为热门话题,同时EUS治疗可能性的实现(从EUS引导下坏死组织清除术到胃肠吻合术)以及ERCP借助辅助技术(胰管外超声(EDUS)、胰管内超声(IDUS)、带活检的胰胆管镜检查和基于探头的共聚焦激光内镜显微镜检查(pCLE))回归其最初的诊断目的。在这篇文献综述中,我们回顾了EUS和ERCP的近期历史,报告了EURCP概念临床应用的实例,并探讨了在仅一次内镜检查中同时进行这两种操作的选择,及其对患者、内镜医师和医疗保健系统的积极影响。在过去几年里,我们还评估了一步将EUS和ERCP整合到单一内镜器械中的可能性,但围绕这种方法仍存在一些障碍。